Dna X Inc (SONM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 27,566 | 26,835 | 25,801 | 24,118 | 20,497 |
| Cost of Goods | 21,963 | 22,409 | 21,626 | 20,186 | 17,181 |
| Gross Profit | 5,603 | 4,426 | 4,175 | 3,932 | 3,316 |
| Operating Expenses | 5,878 | 4,088 | 4,468 | 5,177 | 5,426 |
| Operating Income | 688 | 747 | 333 | -1,059 | -1,929 |
| Interest Expense | 6 | 5 | 0 | 1 | 22 |
| Other Income | -59 | -161 | 7 | 1 | 415 |
| Pre-tax Income | 623 | 581 | 340 | -1,059 | -1,536 |
| Income Tax | 96 | 72 | 113 | -17 | 72 |
| Net Income Continuous | 527 | 509 | 227 | -1,042 | -1,608 |
| Net Income | $527 | $509 | $227 | $-1,042 | $-1,608 |
| EPS Basic Total Ops | 2.16 | 2.16 | 1.80 | 26.98 | -7.19 |
| EPS Basic Continuous Ops | 2.20 | 2.17 | 1.00 | 27.59 | -8.01 |
| EPS Diluted Total Ops | 2.16 | 1.98 | 1.80 | 26.98 | -7.19 |
| EPS Diluted Continuous Ops | 2.15 | 2.05 | 0.99 | 27.59 | -8.01 |
| EBITDA(a) | $755 | $1,300 | $963 | $1,322 | $-1,921 |